NCT06454383
- Conditions
- Advanced Pancreatic Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Clinical trial condition
Unresectable Pancreatic Ductal Adenocarcinoma
Explore clinical trials studying Unresectable Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5 public trials
2 recruiting studies
Unresectable Pancreatic Ductal Adenocarcinoma trial results
NCT04005690
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +13 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Not Yet Recruiting
Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a, for Advanced Pancreatic Ductal Adenocarcinoma
NCT07619521
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +10 more
- Locations
-
Not specified
Active, Not Recruiting
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer
NCT04887805
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +12 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, Not Recruiting
Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
NCT04821284
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
- Locations
-
- Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
- Haukeland University Hospital Bergen, Norway